TrialThe Journal of antimicrobial chemotherapy2021

Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial.

Fatemeh Roozbeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.